← back to search

Yakun Yang

PLA Army Engineering University · CN
Area of research
Endocrinology, Diabetes and Metabolism · Genetics
Research interest
Research interests include Pituitary Gland Disorders and Treatments, Glioma Diagnosis and Treatment, Cancer, Hypoxia, and Metabolism, and Growth Hormone and Insulin-like Growth Factors.
h-index
17
citations
812
works
58
NIH funding
primary concept
email

Recent publications

Depression-related innate immune genes and pan-cancer gene analysis and validation
Frontiers in Genetics 2025cited by 2position: firstdoi
Comprehensive bioinformatics and in vivo validation reveal key molecular drivers of diabetic nephropathy progression
Frontiers in Endocrinology 2025cited by 1position: firstdoi
The Impact of Hyperuricemia on Pharmacokinetics in Sprague–Dawley Rats
European Journal of Drug Metabolism and Pharmacokinetics 2025cited by 0position: middledoi
Mechanistic insights into the ameliorative effects of hypoxia-induced myocardial injury by Corydalis yanhusuo total alkaloids: based on network pharmacology and experiment verification
Frontiers in Pharmacology 2024cited by 4position: middledoi
Exploring the Roles of Key Mediators IKBKE and HSPA1A in Alzheimer’s Disease and Hepatocellular Carcinoma through Bioinformatics Analysis
International Journal of Molecular Sciences 2024cited by 2position: middledoi
Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway
Drug Design Development and Therapy 2022cited by 33position: middledoi
Mechanisms of cinnamic aldehyde against myocardial ischemia/hypoxia injury in vivo and in vitro: Involvement of regulating PI3K/AKT signaling pathway
Biomedicine & Pharmacotherapy 2022cited by 27position: middledoi
Exploring the Mechanism of Danshensu in the Treatment of Doxorubicin-Induced Cardiotoxicity Based on Network Pharmacology and Experimental Evaluation
Frontiers in Cardiovascular Medicine 2022cited by 24position: middledoi
Protective mechanisms of 10-gingerol against myocardial ischemia may involve activation of JAK2/STAT3 pathway and regulation of Ca2+ homeostasis
Biomedicine & Pharmacotherapy 2022cited by 21position: middledoi
Protective effects and possible mechanism of 6-gingerol against arsenic trioxide-induced nephrotoxicity based on network pharmacological analysis and experimental validation
International Immunopharmacology 2022cited by 16position: middledoi
Protective Effects of 6-Gingerol on Cardiotoxicity Induced by Arsenic Trioxide Through AMPK/SIRT1/PGC-1α Signaling Pathway
Frontiers in Pharmacology 2022cited by 15position: middledoi
Protein disulfide isomerase modulation of TRPV1 controls heat hyperalgesia in chronic pain
Cell Reports 2022cited by 14position: middledoi
Ameliorative effects of Danshensu from the functional food Salvia miltiorrhiza against arsenic trioxide-induced cardiac toxicity in vivo and in vitro: Involvement of inhibiting the AKT/IKK/NF-κB signaling pathway
Journal of Functional Foods 2022cited by 6position: firstdoi
Inhibition of human ether-à-go-go-related gene K+ currents expressed in HEK293 cells by three gingerol components from ginger
Journal of Pharmacy and Pharmacology 2022cited by 4position: middledoi
Photothermal Modulation of Depression‐Related Ion Channel Function through Conjugated Polymer Nanoparticles
Advanced Functional Materials 2021cited by 40position: middledoi
Magnesium Isoglycyrrhizinate Alleviates Arsenic Trioxide-Induced Cardiotoxicity: Contribution of Nrf2 and TLR4/NF-κB Signaling Pathway
Drug Design Development and Therapy 2021cited by 34position: middledoi
Cdk5-Mediated Phosphorylation of Sirt1 Contributes to Podocyte Mitochondrial Dysfunction in Diabetic Nephropathy
Antioxidants and Redox Signaling 2020cited by 41position: middledoi
Erratum to: The Clinical Utility of TIMP3 Expression in ACTH-Secreting Pituitary Tumor
Journal of Molecular Neuroscience 2016cited by 0position: middledoi
The Clinical Utility of TIMP3 Expression in ACTH-Secreting Pituitary Tumor
Journal of Molecular Neuroscience 2015cited by 10position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 6 papers (2022–2024)Li Chu · Guangzhou University of Chinese Medicine6 papers (2021–2024)Bin Zheng · Zhejiang Ocean University5 papers (2021–2022)Xue Han · University of Shanghai for Science and Technology5 papers (2022–2022)Shengjiang Guan · State Administration of Traditional Chinese Medicine of the People's Republic of China4 papers (2022–2022)Qingzhong Jia · Hebei Medical University4 papers (2022–2022) · 4 papers (2022–2022)Xue Han · Xinyang Normal University3 papers (2022–2024) · 3 papers (2022–2022)Hailin Zhang · Hebei Medical University3 papers (2021–2024)Zhonglin Wu · Hangzhou First People's Hospital2 papers (2022–2022)Xinjie Bao · Jiangsu University2 papers (2015–2016)Xiaohai Liu · Zhengzhou University2 papers (2015–2016)Congxin Dai · Dalian Medical University2 papers (2015–2016)Muqing Zhang · Montreal Neurological Institute and Hospital2 papers (2022–2022) · 2 papers (2015–2016)Bowen Sun · Guangzhou University of Chinese Medicine2 papers (2015–2016) · 2 papers (2022–2022)Hailong An · Virginia Commonwealth University2 papers (2021–2022)Shijiang Sun · First Affiliated Hospital of Hebei Medical University2 papers (2022–2022)